The latest report by IMARC Group, titled “Neurotechnology Market Report by Product Type (Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants), End User (Hospitals, Clinics, Diagnostic Centres, Ambulatory Surgical Centres), and Region 2024-2032“, The global neurotechnology market size reached US$ 11.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.2 Billion by 2032, exhibiting a growth rate (CAGR) of 10.54% during 2024-2032.
Neurotechnology refers to the advanced set of technologies specifically engineered to interact with or monitor the nervous system, including the brain and peripheral nerves. These technologies encompass a wide range of applications, from medical interventions like deep brain stimulation for treating Parkinson’s disease to wearable devices that monitor brain activity for improving mental health. The technology also includes neural interfaces, brain-computer interfaces, neuroprosthetics, and various software solutions aimed at decoding neural signals. As a result, neurotechnology finds extensive applications in healthcare settings, research laboratories, and consumer markets, offering innovative ways to diagnose, monitor, and treat numerous neurological conditions and enhance human cognition and machine interaction.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/neurotechnology-market/requestsample
Neurotechnology Market Trends and Drivers:
The global neurotechnology market is primarily driven by the rising prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, and Parkinson’s disease, necessitating advanced diagnostic and therapeutic options. Additionally, hefty investments in research and development (R&D) activities in neuroscience are fueling technological innovations, making treatments more effective and less invasive. In line with this, the increasing acceptance of wearable neurotechnology among consumers for applications like stress management and cognitive improvement represents another major growth-inducing factor. Furthermore, escalating regulatory support for new and advanced neurotechnology, coupled with heightened mental health awareness, is positively influencing the market growth. Besides this, the rise in the adoption of machine learning (ML) and artificial intelligence (AI) technologies to interpret complex neural data sets is paving the way for the next wave of innovations in the field, thus fostering market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Product Type Insights:
- Imaging Modalities
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Neurostimulation
- Transcranial Magnetic Stimulation (TMS)
- Transcranial Direct Current Stimulation (TDCS)
- Cranial Surface Measurement
- Electroencephalography (EEG)
- Magnetoencephalography (MEG)
- Neurological Implants
End User Insights:
- Hospitals
- Clinics
- Diagnostic Centres
- Ambulatory Surgical Centres
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Allengers Medical Systems Ltd
- Canon Medical Systems Corporation (Canon Inc.)
- Elekta Solutions AB
- GE HealthCare Technologies Inc. (General Electric)
- Koninklijke Philips N.V.
- Natus Medical Incorporated
- Shimadzu Corporation
- Siemens Healthcare GmbH (Siemens AG)
- The Magstim Company Limited
- Tristan Technologies Inc.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
